This is the authors' abstract. We don't add key points for this paper.
The new World Health Organization/European Orga-nization for Research and Treatment of Cancer (WHO-EORTC) consensus classification for cutaneous lympho-mas recognizes two main groups of CD56+ lymphomas: extranodal natural killer (NK)/T-cell lymphoma nasal type, and CD56+ haematodermic neoplasm (formerly known as blastic NK cell lymphoma (1). NK/T-cell lymphoma nasal type is the most common lymphoma type among primary lymphomas of the nasal cavity (2).It presents clinically as a nasal mass and may involve the skin secondarily, where it often presents as a mid-facial destructive tumour or as multiple distant erythematous nodules, which can evolve to ulceration (3). There is a strong association with Epstein-Barr virus (4).We report here a patient with an extranodal NK/T-cell lymphoma nasal type with cutaneous involvement, in which the clinical presentation mimicked pyoderma gangrenosum.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Delgado‐Jiménez et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: